ALL |
META-ANALYSIS |
CITATIONS |
|
Benefit-Cost Summary Statistics Per Participant | ||||||
---|---|---|---|---|---|---|
Benefits to: | ||||||
Taxpayers | $7 | Benefits minus costs | ($405) | |||
Participants | $2 | Benefit to cost ratio | ($0.44) | |||
Others | $5 | Chance the program will produce | ||||
Indirect | ($137) | benefits greater than the costs | 48% | |||
Total benefits | ($123) | |||||
Net program cost | ($282) | |||||
Benefits minus cost | ($405) | |||||
Meta-Analysis of Program Effects | ||||||||||||
Outcomes measured | Treatment age | No. of effect sizes | Treatment N | Effect sizes (ES) and standard errors (SE) used in the benefit-cost analysis | Unadjusted effect size (random effects model) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
First time ES is estimated | Second time ES is estimated | |||||||||||
ES | SE | Age | ES | SE | Age | ES | p-value | |||||
Major depressive disorder Clinical diagnosis of major depression or symptoms measured on a validated scale. |
16 | 4 | 290 | -0.149 | 0.090 | 16 | 0.000 | 0.310 | 18 | -0.389 | 0.001 | |
Substance use^ Nonspecified substance use (i.e., alcohol, cannabis, or illicit drugs) that does not rise to the level of "disordered." |
16 | 3 | 240 | -0.065 | 0.096 | 16 | n/a | n/a | n/a | -0.171 | 0.365 |
Detailed Monetary Benefit Estimates Per Participant | ||||||
Affected outcome: | Resulting benefits:1 | Benefits accrue to: | ||||
---|---|---|---|---|---|---|
Taxpayers | Participants | Others2 | Indirect3 | Total |
||
Major depressive disorder | K-12 grade repetition | $2 | $0 | $0 | $1 | $2 |
Labor market earnings associated with major depression | $0 | $0 | $0 | $0 | $0 | |
Health care associated with major depression | $5 | $1 | $5 | $2 | $14 | |
Mortality associated with depression | $0 | $0 | $0 | $1 | $1 | |
Program cost | Adjustment for deadweight cost of program | $0 | $0 | $0 | ($141) | ($141) |
Totals | $7 | $2 | $5 | ($137) | ($123) | |
Detailed Annual Cost Estimates Per Participant | ||||
Annual cost | Year dollars | Summary | ||
---|---|---|---|---|
Program costs | $234 | 2017 | Present value of net program costs (in 2023 dollars) | ($282) |
Comparison costs | $0 | 2017 | Cost range (+ or -) | 20% |
Benefits Minus Costs |
Benefits by Perspective |
Taxpayer Benefits by Source of Value |
Benefits Minus Costs Over Time (Cumulative Discounted Dollars) |
The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment. |
Rohde, P., Stice, E., Shaw, H., & Gau, J.M. (2014). Cognitive-behavioral group depression prevention compared to bibliotherapy and brochure control: nonsignificant effects in pilot effectiveness trial with college students. Behaviour Research and Therapy, 55, 48-53.
Rohde, P., Stice, E., Shaw, H., & Gau, J.M. (2014). Effectiveness trial of an indicated cognitive-behavioral group adolescent depression prevention program versus bibliotherapy and brochure control at 1- and 2-year follow-up. Unpublished Manuscript.
Stice, E., Burton, E., Bearman, S.K., & Rohde, P. (2006). Randomized trial of a brief depression prevention program: An elusive search for a psychosocial placebo control condition. Behaviour Research and Therapy, 45(5), 863-876.
Stice, E., Rohde, P., Seeley, J.R., & Gau, J.M. (2008). Brief cognitive-behavioral depression prevention program for high-risk adolescents outperforms two alternative interventions: A randomized efficacy trial. Journal of Consulting and Clinical Psychology, 76(4), 595-606.